BAXTER 0.18% SODIUM CHLORIDE and 4% GLUCOSE 500mL injection AHB1253 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.18% sodium chloride and 4% glucose 500ml injection ahb1253

baxter healthcare pty ltd - glucose, quantity: 40 g/l; sodium chloride, quantity: 1.8 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.3% SODIUM CHLORIDE and 3.3% GLUCOSE 500mL injection AHB1033 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.3% sodium chloride and 3.3% glucose 500ml injection ahb1033

baxter healthcare pty ltd - glucose, quantity: 33 g/l; sodium chloride, quantity: 3 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.45% SODIUM CHLORIDE and 2.5% GLUCOSE 500mL injection AHB1023 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.45% sodium chloride and 2.5% glucose 500ml injection ahb1023

baxter healthcare pty ltd - glucose, quantity: 25 g/l; sodium chloride, quantity: 4.5 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

ULTRAVIST 370 iopromide 384.5 g/500 mL solution for injection bottle Australia - English - Department of Health (Therapeutic Goods Administration)

ultravist 370 iopromide 384.5 g/500 ml solution for injection bottle

bayer australia ltd - iopromide, quantity: 768.86 mg/ml - injection, solution - excipient ingredients: dilute hydrochloric acid; sodium calcium edetate; trometamol; water for injections; sodium hydroxide - ultravist is indicated for all angiographic and urographic examinations and for contrast enhancement in computerised tomography.,ultravist 300 or 370 is indicated for use in contrast-enhanced mammography (cem) in adults, to visualise known or suspected lesions of the breast as an adjunct to mammography (with or without ultrasound).

OPTIRAY 350 ioversol 370.5 g/500 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

optiray 350 ioversol 370.5 g/500 ml injection vial

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium calcium edetate; sodium hydroxide; trometamol hydrochloride; water for injections; trometamol - optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include cerebral, coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretory urography.

Water for Injection (Lumacina) New Zealand - English - Medsafe (Medicines Safety Authority)

water for injection (lumacina)

lumacina new zealand - water for injection 100% - solution for injection - 100 % - active: water for injection 100%

Water for Injections Ph. Eur. Malta - English - Medicines Authority

water for injections ph. eur.

baxter healthcare limited - water for, injections - solvent for parenteral use - water for injections 100 percent weight/volume - all other non-therapeutic products

Water for Injections CSL Behring solvent for parental use Malta - English - Medicines Authority

water for injections csl behring solvent for parental use

csl behring gmbh emil-von-behring-strasse 76, 35041 marburg, germany - water for, injection - solvent for parenteral use - water for injection - all other non-therapeutic products

Water for Injections Ph. Eur. Malta - English - Medicines Authority

water for injections ph. eur.

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - water for, injections - solvent for parenteral use - water for injections 100 % (w/v) - all other non-therapeutic products

Intralipid 20% 500mL injection bottle Australia - English - Department of Health (Therapeutic Goods Administration)

intralipid 20% 500ml injection bottle

fresenius kabi australia pty ltd - soya oil, quantity: 200 g/l - injection, intravenous infusion - excipient ingredients: glycerol; egg lecithin; water for injections - indications: part of the intravenous diet in all parenteral nutrition indications including:- 1. preoperative and postoperative nutritional disturbances where an improved nitrogen balance is required; 2. nutritional disorders or disturbances of nitrogen balance due to inadequate or failing intestinal absorption caused by tumours in the gastrointestinal tract, acute or chronic intestinal diseases (peritonitis, ulcerative colitis, terminal ileitis); 3. burns, to reduce the frequently-excessive nitrogen losses; 4. prolonged unconsciousness, eg. following cranial trauma or poisoning in cases where enteral feeding is inappropriate or impossible; 5.impaired renal function where a concentrated source of energy may be indicated to reduce protein breakdown; 6. cachexia; 7. patients with essential fatty acid deficiency who cannot maintain or restore a normal essential fatty acid pattern by oral intake.